# Astellas Pharma Inc. Astellas Pharma settles US patent litigation with Zydus Lifesciences for $120 million over generic bladder disorder drug. The company's expansion in Europe has also been recognized as a top investment project. ### About Astellas Pharma Inc. Astellas Pharma Inc. is a global pharmaceutical company focused on developing innovative medicines. ### Insights - Astellas Pharma Inc. creators is up 33.77% from the previous week. - Astellas Pharma Inc. engagements is up 288.64% from the previous week. - Astellas Pharma Inc. mentions is up 48.45% from the previous month. - Astellas Pharma Inc. posts created is up 321.05% from the previous week. - Astellas Pharma Inc. Price hit a 52-Week high of $2,545 for the hour - Astellas Pharma Inc. Price hit an all time of $2,545 for the hour ### Price: $  [Price 24-Hour Time-Series Raw Data](/topic/$4503t/time-series/close.tsv) The stock price has reached new highs, driven by positive sentiment from XTANDI's clinical trial results and speculation about a potential TSHA buyout, indicating strong market confidence in the company's future prospects. 1-Year High: $2,531.50 on 2026-02-10 1-Year Low: $1,257 on 2025-04-09 ### AltRank: [---]  [AltRank 24-Hour Time-Series Raw Data](/topic/$4503t/time-series/alt_rank.tsv) Astellas Pharma Inc. is currently AltRank #621 based on combined combined social and market metrics Daily Average: [---] 1-Year High: [-----] on 2025-03-10 1-Year Low: [---] on 2025-12-25 ### Galaxy Score: [--]  [Galaxy Score 24-Hour Time-Series Raw Data](/topic/$4503t/time-series/galaxy_score.tsv) Current Value: [--] Daily Average: [--] 1-Year High: [--] on 2025-07-29 1-Year Low: [--] on 2025-03-23 ### Engagements: [-----] (24h)  [Engagements 24-Hour Time-Series Raw Data](/topic/$4503t/time-series/interactions.tsv) Current Value: [-----] Daily Average: [-----] [--] Week: [------] +289% [--] Month: [-------] +5.90% [--] Months: [-------] -45% [--] Year: [---------] +240% 1-Year High: [-------] on 2025-03-28 1-Year Low: [---] on 2025-08-09 Engagements by network (24h): News: [--] X: [-----] TikTok: [---] Reddit: [---] YouTube: [--] ### Mentions: [---] (24h)  [Mentions 24-Hour Time-Series Raw Data](/topic/$4503t/time-series/posts_active.tsv) Current Value: [---] Daily Average: [--] [--] Week: [---] +36% [--] Month: [---] +48% [--] Months: [-----] -8.10% [--] Year: [-----] +146% 1-Year High: [---] on 2025-07-18 1-Year Low: [--] on 2025-08-10 Mentions by network (24h): News: [--] X: [--] TikTok: [--] Reddit: [--] YouTube: [--] ### Creators: [--] (24h)  [Creators 24-Hour Time-Series Raw Data](/topic/$4503t/time-series/contributors_active.tsv) [--] unique social accounts have posts mentioning Astellas Pharma Inc. in the last [--] hours which is down 35% from [---] in the previous [--] hours Daily Average: [--] [--] Week: [---] +34% [--] Month: [---] +30% [--] Months: [---] -16% [--] Year: [-----] +127% 1-Year High: [---] on 2025-07-18 1-Year Low: [--] on 2025-08-10 The most influential creators that mention Astellas Pharma Inc. in the last [--] hours | Creator | Rank | Followers | Posts | Engagements | | ------- | ---- | --------- | ----- | ----------- | | [@EconomicTimes](/creator/twitter/EconomicTimes) | [--] | [---------] | [--] | [-----] | | [@REDBOXINDIA](/creator/twitter/REDBOXINDIA) | [--] | [-------] | [--] | [--] | | [@H2AK119ub](/creator/reddit/H2AK119ub) | [--] | | [--] | [--] | | [@stellanewslife](/creator/twitter/stellanewslife) | [--] | [-----] | [--] | [--] | | [@AstellasUS](/creator/twitter/AstellasUS) | [--] | [------] | [--] | [--] | | [@thehindubiz](/creator/twitter/thehindubiz) | [--] | [------] | [--] | [--] | | [@Ryansikorski10](/creator/twitter/Ryansikorski10) | [--] | [------] | [--] | [--] | | [@CNBCTV18Live](/creator/twitter/CNBCTV18Live) | [--] | [---------] | [--] | [--] | | [@DryBoysenberry596](/creator/reddit/DryBoysenberry596) | [--] | | [--] | [--] | | [@Plenty-Spread6431](/creator/reddit/Plenty-Spread6431) | [--] | | [--] | [--] | [View More](/list/creators/$4503t/100) ### Sentiment: 83%  [Sentiment 24-Hour Time-Series Raw Data](/topic/$4503t/time-series/sentiment.tsv) Current Value: 83% Daily Average: 87% [--] Week: 78% -22% [--] Month: 80% +1% [--] Months: 80% no change [--] Year: 80% -13% 1-Year High: 100% on 2025-02-18 1-Year Low: 40% on 2025-07-17 Most Supportive Themes: - XTANDI's Positive Clinical Data: (60%) Positive clinical data for XTANDI showing a significant reduction in death risk for advanced prostate cancer patients. - Potential TSHA Buyout: (20%) Speculation and discussion surrounding a potential acquisition of TSHA, which could impact Astellas's strategic positioning. - STAT6 Inhibitor Programs: (10%) Advancements and discussions related to Astellas's STAT6 Inhibitor Programs, indicating progress in their research and development pipeline. Most Critical Themes: - Mental Health and Diagnostic Challenges: (1%) Concerns and discussions regarding mental health issues and the complexities associated with cancer diagnosis. ### Market Cap: $undefined  [Market Cap 24-Hour Time-Series Raw Data](/topic/$4503t/time-series/market_cap.tsv) Current Value: $undefined Daily Average: $2,637,094,225,476 1-Year High: $2,689,650,162,953 on 2025-03-27 1-Year Low: $2,588,508,576,126 on 2025-03-11 ### Top Astellas Pharma Inc. Social Posts Top posts by engagements in the last [--] hours *Showing a maximum of [--] top social posts without a LunarCrush subscription.* "Zydus settles US Mirabegron patent dispute with Astellas for $120 million https://economictimes.indiatimes.com/industry/healthcare/biotech/pharmaceuticals/zydus-settles-us-mirabegron-patent-dispute-with-astellas-for-120-million/articleshow/128236033.cms https://economictimes.indiatimes.com/industry/healthcare/biotech/pharmaceuticals/zydus-settles-us-mirabegron-patent-dispute-with-astellas-for-120-million/articleshow/128236033.cms" [X Link](https://x.com/EconomicTimes/status/2022606792753115643) [@EconomicTimes](/creator/x/EconomicTimes) 2026-02-14T09:40Z 4.3M followers, [----] engagements "Astellas expansion recognised as being among Europes top investment projects https://www.radiokerry.ie/news/astellas-expansion-recognised-as-being-among-europes-top-investment-projects-471794 https://www.radiokerry.ie/news/astellas-expansion-recognised-as-being-among-europes-top-investment-projects-471794" [X Link](https://x.com/radiokerrynews/status/2022357043294724108) [@radiokerrynews](/creator/x/radiokerrynews) 2026-02-13T17:07Z 17.3K followers, [---] engagements "#womenshealthnursepractitioner #whnp #familynursepractitioner #fnp Ferring Pharmaceuticals Bayer Abbvie Vitrolife Merck I cant get a nonclinical role as a nurse/ NP because all I have is womens health experience Astellas Twentyeight health Organon Ferring Pharmaceuticals Bayer Abbvie Vitrolife Merck I cant get a nonclinical role as a nurse/ NP because all I have is womens health experience Astellas Twentyeight health Organon" [TikTok Link](https://www.tiktok.com/@npteeks/video/7605413533806775582) [@npteeks](/creator/tiktok/npteeks) 2026-02-11T01:28Z 24.8K followers, 21.7K engagements Limited data mode. Full metrics available with subscription: lunarcrush.com/pricing
Astellas Pharma settles US patent litigation with Zydus Lifesciences for $120 million over generic bladder disorder drug. The company's expansion in Europe has also been recognized as a top investment project.
Astellas Pharma Inc. is a global pharmaceutical company focused on developing innovative medicines.
Price 24-Hour Time-Series Raw Data
The stock price has reached new highs, driven by positive sentiment from XTANDI's clinical trial results and speculation about a potential TSHA buyout, indicating strong market confidence in the company's future prospects.
1-Year High: $2,531.50 on 2026-02-10
1-Year Low: $1,257 on 2025-04-09
AltRank 24-Hour Time-Series Raw Data
Astellas Pharma Inc. is currently AltRank #621 based on combined combined social and market metrics
Daily Average: [---]
1-Year High: [-----] on 2025-03-10
1-Year Low: [---] on 2025-12-25
Galaxy Score 24-Hour Time-Series Raw Data
Current Value: [--]
Daily Average: [--]
1-Year High: [--] on 2025-07-29
1-Year Low: [--] on 2025-03-23
Engagements 24-Hour Time-Series Raw Data
Current Value: [-----]
Daily Average: [-----]
[--] Week: [------] +289%
[--] Month: [-------] +5.90%
[--] Months: [-------] -45%
[--] Year: [---------] +240%
1-Year High: [-------] on 2025-03-28
1-Year Low: [---] on 2025-08-09
Engagements by network (24h): News: [--] X: [-----] TikTok: [---] Reddit: [---] YouTube: [--]
Mentions 24-Hour Time-Series Raw Data
Current Value: [---]
Daily Average: [--]
[--] Week: [---] +36%
[--] Month: [---] +48%
[--] Months: [-----] -8.10%
[--] Year: [-----] +146%
1-Year High: [---] on 2025-07-18
1-Year Low: [--] on 2025-08-10
Mentions by network (24h): News: [--] X: [--] TikTok: [--] Reddit: [--] YouTube: [--]
Creators 24-Hour Time-Series Raw Data
[--] unique social accounts have posts mentioning Astellas Pharma Inc. in the last [--] hours which is down 35% from [---] in the previous [--] hours
Daily Average: [--]
[--] Week: [---] +34%
[--] Month: [---] +30%
[--] Months: [---] -16%
[--] Year: [-----] +127%
1-Year High: [---] on 2025-07-18
1-Year Low: [--] on 2025-08-10
The most influential creators that mention Astellas Pharma Inc. in the last [--] hours
| Creator | Rank | Followers | Posts | Engagements |
|---|---|---|---|---|
| @EconomicTimes | [--] | [---------] | [--] | [-----] |
| @REDBOXINDIA | [--] | [-------] | [--] | [--] |
| @H2AK119ub | [--] | [--] | [--] | |
| @stellanewslife | [--] | [-----] | [--] | [--] |
| @AstellasUS | [--] | [------] | [--] | [--] |
| @thehindubiz | [--] | [------] | [--] | [--] |
| @Ryansikorski10 | [--] | [------] | [--] | [--] |
| @CNBCTV18Live | [--] | [---------] | [--] | [--] |
| @DryBoysenberry596 | [--] | [--] | [--] | |
| @Plenty-Spread6431 | [--] | [--] | [--] |
Sentiment 24-Hour Time-Series Raw Data
Current Value: 83%
Daily Average: 87%
[--] Week: 78% -22%
[--] Month: 80% +1%
[--] Months: 80% no change
[--] Year: 80% -13%
1-Year High: 100% on 2025-02-18
1-Year Low: 40% on 2025-07-17
Most Supportive Themes:
Most Critical Themes:
Market Cap 24-Hour Time-Series Raw Data
Current Value: $undefined
Daily Average: $2,637,094,225,476
1-Year High: $2,689,650,162,953 on 2025-03-27
1-Year Low: $2,588,508,576,126 on 2025-03-11
Top posts by engagements in the last [--] hours
Showing a maximum of [--] top social posts without a LunarCrush subscription.
"Zydus settles US Mirabegron patent dispute with Astellas for $120 million https://economictimes.indiatimes.com/industry/healthcare/biotech/pharmaceuticals/zydus-settles-us-mirabegron-patent-dispute-with-astellas-for-120-million/articleshow/128236033.cms https://economictimes.indiatimes.com/industry/healthcare/biotech/pharmaceuticals/zydus-settles-us-mirabegron-patent-dispute-with-astellas-for-120-million/articleshow/128236033.cms"
X Link @EconomicTimes 2026-02-14T09:40Z 4.3M followers, [----] engagements
"Astellas expansion recognised as being among Europes top investment projects https://www.radiokerry.ie/news/astellas-expansion-recognised-as-being-among-europes-top-investment-projects-471794 https://www.radiokerry.ie/news/astellas-expansion-recognised-as-being-among-europes-top-investment-projects-471794"
X Link @radiokerrynews 2026-02-13T17:07Z 17.3K followers, [---] engagements
"#womenshealthnursepractitioner #whnp #familynursepractitioner #fnp Ferring Pharmaceuticals Bayer Abbvie Vitrolife Merck I cant get a nonclinical role as a nurse/ NP because all I have is womens health experience Astellas Twentyeight health Organon Ferring Pharmaceuticals Bayer Abbvie Vitrolife Merck I cant get a nonclinical role as a nurse/ NP because all I have is womens health experience Astellas Twentyeight health Organon"
TikTok Link @npteeks 2026-02-11T01:28Z 24.8K followers, 21.7K engagements
Limited data mode. Full metrics available with subscription: lunarcrush.com/pricing
/topic/$4503t